SS Innovations International (NASDAQ: SSII) is gaining commercial traction with its SSi Mantra surgical robotic platform, according to CEO Dr. Sudhir Srivastava, who recently spoke with The Motley Fool’s Rachel Warren. The company has now performed more than 15,000 procedures using its systems, including approximately 750 cardiac surgeries, signaling growing adoption of its technology in a market long dominated by larger competitors. The interview, available via this link, also revealed that over 200 telesurgeries have been completed, including 27 cardiac cases, as the company seeks to extend specialist care to underserved regions.
The significance of these numbers lies in what they represent for the broader adoption of robotic surgery. Telesurgery, in particular, could allow expert surgeons to operate on patients in remote or underserved areas, potentially addressing disparities in access to specialized care. Srivastava highlighted the SSi Mantra’s differentiated engineering, including 4K 3D visualization, surgeon-controlled anatomical imaging, and a modular design that supports up to five robotic arms. These features, he suggested, make the platform both versatile and cost-effective, which is critical for driving adoption in emerging markets and ambulatory surgery centers.
SS Innovations is also preparing to expand its manufacturing footprint in India with a planned 10-acre facility, aiming to bring additional production capabilities in-house. This move could enhance supply chain control and support cost efficiencies as the company scales. Regulatory applications in Europe and the United States are progressing, with management targeting international expansion through direct sales and opportunities in ambulatory surgery centers. The company’s commercial momentum is evident in its first-half 2026 revenue, which increased approximately 66% year-over-year to about $25 million.
For investors, the company’s ability to secure regulatory approvals in major markets will be key to unlocking further growth. The SSi Mantra’s affordability and advanced features position it to compete in a rapidly evolving field. As SS Innovations International (NASDAQ: SSII) continues to expand its global reach, the outcomes of its regulatory submissions and the success of its manufacturing expansion will be closely watched. More details from the interview can be found in the full article, and ongoing updates are available in the company’s newsroom at https://ibn.fm/SSII.
